SAN FRANCISCO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Following the company's release of its latest financial report, three analysts weighed in on the results.

Included in this article is:  Viveve Medical Inc. (NASDAQ:VIVE)

In a Nov. 8, 2017, press release, Viveve Medical Inc., a women's health and wellness company, announced record Q3/17 sales of $4.1 million," a 120% year-over-year (YOY) increase. "These results demonstrate continued strong demand for our innovative technology and the Geneveve treatment globally, particularly in North America, our largest commercial market," said Patricia Scheller, the corporation's CEO and director.

Revenue derived from the sale of 60 systems, 47 in North America, and 2,724 treatment tips. "The increasing demand we have seen since launching the Viveve System in Q3/15 reinforces the size of the worldwide opportunity and sets the stage for continuing global adoption through the remainder of the year and into 2018," Scheller concluded.

Viveve's Q3/17 global sales led to greater gross profit of $2 million, or 49% of revenue. This compares to that of Q3/16, which was $691,000, or 37% of revenue.

Continue reading this article: Analysts Say Medical Device Firm Sees Record Quarterly Revenue Growth, 120% YOY

About Streetwise Reports – The Life Sciences Report

Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.

DISCLOSURES:

The following company mentioned in this article is a billboard sponsor of Streetwise Reports: Viveve Medical Inc. Streetwise Reports does not accept stock in exchange for its services. Click here for important disclosures about sponsor fees. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. 

Please see the end of the article for the complete disclosures: Analysts Say Medical Device Firm Sees Record Quarterly Revenue Growth, 120% YOY

Contact Information: Carrie Beal Amaro- Publisher (cbealamaro@streetwisereports.com)

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.